Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 3 Insider Initial Statement of Ownership
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 4 Grant or award Director acquired 1,440,923 shares (grant or award)
  4. 8-K Event Material agreement · Other events
  5. 424B5 Offering Prospectus
  6. 10-Q Report Quarterly Report
  7. 424B5 Offering Prospectus
  8. 8-K Event Material agreement
  9. 8-K Event Material agreement · New debt or obligation
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change · Other events
  13. 4 Open-market buy Director bought 24,264 shares at $3.64 ($88,411)
  14. 4 Open-market buy Director bought 75,736 shares at an average $3.64 ($275,505)
  15. 8-K Event Other events
  16. 8-K Event Executive or director change
  17. 4 Open-market buy SVP, Chief Medical Officer bought 3,514 shares at an average $2.93 ($10,288)
  18. 10-Q Report Quarterly Report
  19. 4 Open-market sale Sr. VP, Chief Comm. Officer sold 4,000 shares at $3.21 ($12,840)
  20. 4 Grant or award Director acquired 7,722 shares (grant or award)

Page 51 of 62 · 1,224 filings